LLA vs. IDHC, DXRX, AGL, YGEN, ABDX, PRM, GDR, VRCI, GENI, and DMTR
Should you be buying LLA.L,0P0001T9GN,0 stock or one of its competitors? The main competitors of LLA.L,0P0001T9GN,0 include Integrated Diagnostics (IDHC), Diaceutics (DXRX), ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), Verici Dx (VRCI), GENinCode (GENI), and Deepmatter Group (DMTR). These companies are all part of the "diagnostics & research" industry.
LLA.L,0P0001T9GN,0 vs.
Integrated Diagnostics (LON:IDHC) and LLA.L,0P0001T9GN,0 (LON:LLA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, community ranking, analyst recommendations and institutional ownership.
43.0% of Integrated Diagnostics shares are held by institutional investors. Comparatively, 5.4% of LLA.L,0P0001T9GN,0 shares are held by institutional investors. 34.0% of Integrated Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Integrated Diagnostics received 56 more outperform votes than LLA.L,0P0001T9GN,0 when rated by MarketBeat users.
In the previous week, Integrated Diagnostics had 1 more articles in the media than LLA.L,0P0001T9GN,0. MarketBeat recorded 1 mentions for Integrated Diagnostics and 0 mentions for LLA.L,0P0001T9GN,0. Integrated Diagnostics' average media sentiment score of 0.59 beat LLA.L,0P0001T9GN,0's score of 0.00 indicating that Integrated Diagnostics is being referred to more favorably in the media.
Integrated Diagnostics has a net margin of 17.21% compared to LLA.L,0P0001T9GN,0's net margin of 0.00%. Integrated Diagnostics' return on equity of 30.45% beat LLA.L,0P0001T9GN,0's return on equity.
Integrated Diagnostics has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, LLA.L,0P0001T9GN,0 has a beta of -0.3, indicating that its share price is 130% less volatile than the S&P 500.
Integrated Diagnostics has higher revenue and earnings than LLA.L,0P0001T9GN,0. LLA.L,0P0001T9GN,0 is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.
Summary
Integrated Diagnostics beats LLA.L,0P0001T9GN,0 on 13 of the 13 factors compared between the two stocks.
Get LLA.L,0P0001T9GN,0 News Delivered to You Automatically
Sign up to receive the latest news and ratings for LLA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LLA.L,0P0001T9GN,0 Competitors List
Related Companies and Tools
This page (LON:LLA) was last updated on 2/22/2025 by MarketBeat.com Staff
